国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Thermotoga neapolitana 50S ribosomal protein L4 (rplD) CSB-YP497266TNL
CSB-EP497266TNL
CSB-BP497266TNL
CSB-MP497266TNL
CSB-EP497266TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana 50S ribosomal protein L29 (rpmC) CSB-YP497267TNL
CSB-EP497267TNL
CSB-BP497267TNL
CSB-MP497267TNL
CSB-EP497267TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana 50S ribosomal protein L30 (rpmD) CSB-YP497268TNL
CSB-EP497268TNL
CSB-BP497268TNL
CSB-MP497268TNL
CSB-EP497268TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana GTPase Der (der) CSB-YP497269TNL
CSB-EP497269TNL
CSB-BP497269TNL
CSB-MP497269TNL
CSB-EP497269TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP497270TNL
CSB-EP497270TNL
CSB-BP497270TNL
CSB-MP497270TNL
CSB-EP497270TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Probable septum site-determining protein MinC (minC) CSB-YP497271TNL
CSB-EP497271TNL
CSB-BP497271TNL
CSB-MP497271TNL
CSB-EP497271TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Heat-inducible transcription repressor HrcA (hrcA) CSB-YP497272TNL
CSB-EP497272TNL
CSB-BP497272TNL
CSB-MP497272TNL
CSB-EP497272TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Threonine--tRNA ligase (thrS), partial CSB-YP497273TNL
CSB-EP497273TNL
CSB-BP497273TNL
CSB-MP497273TNL
CSB-EP497273TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Carbamoyl-phosphate synthase large chain (carB), partial CSB-YP497274TNL
CSB-EP497274TNL
CSB-BP497274TNL
CSB-MP497274TNL
CSB-EP497274TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana 50S ribosomal protein L1 (rplA) CSB-YP497275TNL
CSB-EP497275TNL
CSB-BP497275TNL
CSB-MP497275TNL
CSB-EP497275TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermotoga neapolitana Shikimate dehydrogenase (aroE) CSB-YP497276TNL
CSB-EP497276TNL
CSB-BP497276TNL
CSB-MP497276TNL
CSB-EP497276TNL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Putative Holliday junction resolvase (Cla_0945) CSB-YP497277CZB
CSB-EP497277CZB
CSB-BP497277CZB
CSB-MP497277CZB
CSB-EP497277CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 30S ribosomal protein S16 (rpsP) CSB-YP497278CZB
CSB-EP497278CZB
CSB-BP497278CZB
CSB-MP497278CZB
CSB-EP497278CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari 10 kDa chaperonin (groS) CSB-YP497279CZB
CSB-EP497279CZB
CSB-BP497279CZB
CSB-MP497279CZB
CSB-EP497279CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Leucyl/phenylalanyl-tRNA--protein transferase (aat) CSB-YP497280CZB
CSB-EP497280CZB
CSB-BP497280CZB
CSB-MP497280CZB
CSB-EP497280CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP497281CZB
CSB-EP497281CZB
CSB-BP497281CZB
CSB-MP497281CZB
CSB-EP497281CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP497282CZB
CSB-EP497282CZB
CSB-BP497282CZB
CSB-MP497282CZB
CSB-EP497282CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Dihydrodipicolinate reductase (dapB) CSB-YP497283CZB
CSB-EP497283CZB
CSB-BP497283CZB
CSB-MP497283CZB
CSB-EP497283CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Trigger factor (tig) CSB-YP497284CZB
CSB-EP497284CZB
CSB-BP497284CZB
CSB-MP497284CZB
CSB-EP497284CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter lari Adenine deaminase (Cla_0004) CSB-YP497285CZB
CSB-EP497285CZB
CSB-BP497285CZB
CSB-MP497285CZB
CSB-EP497285CZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>